Pediatr Blood Cancer. 2010 Dec 1;55(6):1217-20.
Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma.
Walsh A, Kelly DR, Vaid YN, Hilliard LM, Friedman GK.
Division of Pediatric Hematology Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
Abstract
Renal medullary carcinoma (RMC) is a rare and aggressive malignancy seen primarily in patients with sickle-cell trait. We report a complete response to carboplatin, paclitaxel, and gemcitabine in a patient with advanced metastatic RMC. Pediatr Blood Cancer. 2010;55:1217-1220.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου